Veterinary Medicines

NEOMYCINE 40 LAPIN-VOLAILLE-PORC ET AGNEAU-CHEVREAU SEVRES

Authorised
  • NEOMYCIN SULFATE
Download as PDF

Product identification

Medicine name:
NEOMYCINE 40 LAPIN-VOLAILLE-PORC ET AGNEAU-CHEVREAU SEVRES
Active substance:
  • NEOMYCIN SULFATE
Target species:
  • Quail
  • Pig
  • Rabbit
  • Sheep (lamb)
  • Sheep
  • Goat (kid)
  • Goat
  • Pheasant
  • Partridge
  • Guinea fowl
  • Goose
  • Duck
  • Chicken
  • Turkey
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    40000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • Oral use
    • Quail
      • Meat and offal
        14
        day
      • Eggs
        0
        day
    • Pig
      • Meat and offal
        14
        day
    • Rabbit
      • Meat and offal
        14
        day
    • Sheep (lamb)
      • Meat and offal
        14
        day
    • Sheep
      • Milk
        no withdrawal period
    • Goat (kid)
      • Meat and offal
        14
        day
    • Goat
      • Milk
        no withdrawal period
    • Pheasant
      • Meat and offal
        14
        day
      • Eggs
        0
        day
    • Partridge
      • Meat and offal
        14
        day
      • Eggs
        0
        day
    • Guinea fowl
      • Meat and offal
        14
        day
      • Eggs
        0
        day
    • Goose
      • Meat and offal
        14
        day
      • Eggs
        0
        day
    • Duck
      • Meat and offal
        14
        day
      • Eggs
        0
        day
    • Chicken
      • Meat and offal
        14
        day
      • Eggs
        0
        day
    • Turkey
      • Meat and offal
        14
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Huvepharma S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/6391074 8/1990
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."